A multicenter, open-label, phase 2 study of NGX-4010 [capsaicin] for the treatment of neuropathic pain in patients with painful HIV-associated neuropathy (HIV-AN) or postherpetic neuralgia (PHN)
Phase of Trial: Phase II
Latest Information Update: 04 Mar 2008
At a glance
- Drugs Capsaicin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 04 Mar 2008 Status changed from in progress to completed.
- 06 Nov 2005 New trial record.